GGrantIndex
← Leaderboards

Deepak Kaushal

University Of Chicago

Google Scholar ↗PubMed ↗ORCID ↗
$47,591,390
Attributed
$75,560,352
Total exposure
59
Grants
49
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $12.8M · FY2006–25
$20M$15M$10M$5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$99,101,541 · 61

By mechanism

R01$53,249,124 · 13
U42$24,407,590 · 3
U19$5,643,187 · 2
UH3$4,733,613 · 1
U01$2,967,748 · 1
C06$1,996,771 · 1

Top collaborators

Most similar at University Of Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Tuberculosis”

Research focus

TuberculosisMycobacterium TuberculosisInfectionAnimalsLungMacaca MulattaNonhuman PrimateResponseImmuneMacacaVaccinesFundingPrimatesGranulomaUnited States National Institutes Of HealthPulmonary TuberculosisDoseResourcesGenesCessation Of LifeAerosolsResearch PersonnelAcquired Immunodeficiency SyndromeCells

Grant awards (131)

Establishment of a SPF Rhesus Macaque Colony$2,417,980
U42 · FY2025 · OD · contact PI
Animal Husbandry Core$2,055,914
U42 · FY2025 · OD · contact PI
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis$1,368,144
R01 · FY2025 · AI
Mechanisms of efficient control of Mycobacterium tuberculosis in the lungs prior to granuloma$1,231,164
R01 · FY2025 · AI · contact PI
Efficacy and Safety of AI-enabled PRS Regimen VI (Clofazimine, Bedaquiline and Pyrazinamide) as Ultra-Short Course Therapy of LTBI in Non-Human Primates in a setting mimicking HIV co-infection$931,829
R01 · FY2025 · AI
Evaluating the safety, immunogenicity and efficacy of a robust attenuated Mtb vaccine in the setting of HIV co-infection$905,998
R01 · FY2025 · AI · contact PI
Targeting trained immunity and Th1/Th17 axis with combination adjuvants$600,000
U01 · FY2025 · AI
Basic Science Core - Imaging$102,118
P30 · FY2025 · AI · contact PI
Establishment of a SPF Rhesus Macaque Colony$2,417,980
U42 · FY2024 · OD · contact PI
Animal Husbandry Core$2,055,916
U42 · FY2024 · OD · contact PI
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis$1,368,144
R01 · FY2024 · AI
Mechanisms of efficient control of Mycobacterium tuberculosis in the lungs prior to granuloma$1,091,124
R01 · FY2024 · AI · contact PI
Efficacy and Safety of AI-enabled PRS Regimen VI (Clofazimine, Bedaquiline and Pyrazinamide) as Ultra-Short Course Therapy of LTBI in Non-Human Primates in a setting mimicking HIV co-infection$934,898
R01 · FY2024 · AI
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis$881,854
R01 · FY2024 · AI
Targeting trained immunity and Th1/Th17 axis with combination adjuvants$600,000
U01 · FY2024 · AI
Basic Science Core - Imaging$125,047
P30 · FY2024 · AI · contact PI
Establishment of a SPF Rhesus Macaque Colony$2,417,980
U42 · FY2023 · OD · contact PI
Animal Husbandry Core$2,055,913
U42 · FY2023 · OD · contact PI
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis$1,415,724
R01 · FY2023 · AI
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants$1,225,642
R01 · FY2023 · HD
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis$897,854
R01 · FY2023 · AI
Targeting trained immunity and Th1/Th17 axis with combination adjuvants$599,999
U01 · FY2023 · AI
Basic Science Core - Imaging$133,347
P30 · FY2023 · AI · contact PI
Establishment of a SPF Rhesus Macaque Colony$2,324,981
U42 · FY2022 · OD · contact PI
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants$1,558,621
R01 · FY2022 · HD
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis$1,363,070
R01 · FY2022 · AI
Immune Correlates of Protection from TB$889,259
R01 · FY2022 · AI · contact PI
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis$869,240
R01 · FY2022 · AI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB$867,304
R01 · FY2022 · AI · contact PI
Targeting trained immunity and Th1/Th17 axis with combination adjuvants$567,749
U01 · FY2022 · AI
Basic Science Core - Imaging$199,894
P30 · FY2022 · AI · contact PI
Establishment of a SPF Rhesus Macaque Colony$2,324,981
U42 · FY2021 · OD · contact PI
Significant expansion of the SNPRC Specific Pathogen Free Rhesus Macaque Colony for AIDS research$1,996,771
C06 · FY2021 · OD · contact PI
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis$1,391,820
R01 · FY2021 · AI
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants$1,225,642
R01 · FY2021 · HD
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB$877,748
R01 · FY2021 · AI · contact PI
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis$720,290
R01 · FY2021 · AI
Targeting trained immunity and Th1/Th17 axis with combination adjuvants$600,000
U01 · FY2021 · AI
Establishment of a SPF Rhesus Macaque Colony$499,999
U42 · FY2021 · OD · contact PI
Baboon model of long term effects of SARS-CoV-2 infection$499,742
P51 · FY2021 · OD
Establishment of a SPF Rhesus Macaque Colony$493,350
U42 · FY2021 · OD · contact PI
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants$466,181
R01 · FY2021 · HD
Womb to Tomb: Developmental Programming and Aging Interactions in Primates$2,657,007
U19 · FY2020 · AG
Establishment of a SPF Rhesus Macaque Colony$2,324,981
U42 · FY2020 · OD · contact PI
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants$1,225,614
R01 · FY2020 · HD
Immune Correlates of Protection from TB$899,913
R01 · FY2020 · AI · contact PI
Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function$898,189
R01 · FY2020 · AI · contact PI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB$872,044
R01 · FY2020 · AI · contact PI
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis$734,665
R01 · FY2020 · AI
Establishment of a SPF Rhesus Macaque Colony$692,634
U42 · FY2020 · OD · contact PI
Significant upgrade and expansion of the Southwest National Primate Research Center Pathology Unit$489,000
S10 · FY2020 · OD · contact PI
Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function-Diversity Supplement$148,967
R01 · FY2020 · AI · contact PI
Womb to Tomb: Developmental Programming and Aging Interactions in Primates$2,644,335
U19 · FY2019 · AG
Establishment of a SPF Rhesus Macaque Colony$2,324,981
U42 · FY2019 · OD
Development of Gleevec for TB and TB/HIV$1,571,205
UH3 · FY2019 · AI
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants$1,200,027
R01 · FY2019 · HD
Immune Correlates of Protection from TB$908,608
R01 · FY2019 · AI · contact PI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB$904,277
R01 · FY2019 · AI · contact PI
Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function$899,688
R01 · FY2019 · AI · contact PI
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection$890,058
R01 · FY2019 · AI · contact PI
ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSIS$800,095
R01 · FY2019 · AI
COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANS$668,570
R01 · FY2019 · AI
Development of Gleevec for TB and TB/HIV$1,534,659
UH3 · FY2018 · AI
Immune Correlates of Protection from TB$1,301,322
R01 · FY2018 · AI · contact PI
Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function$1,034,989
R01 · FY2018 · AI · contact PI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB$837,967
R01 · FY2018 · AI · contact PI
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection$822,232
R01 · FY2018 · AI · contact PI
ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSIS$800,058
R01 · FY2018 · AI
COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANS$726,447
R01 · FY2018 · AI
Macaque T cell signatures of Mtb control$341,845
U19 · FY2018 · AI
Development of Gleevec for TB and TB/HIV$1,627,749
UH3 · FY2017 · AI
ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSIS$877,406
R01 · FY2017 · AI
Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function$873,043
R01 · FY2017 · AI · contact PI
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection$843,809
R01 · FY2017 · AI · contact PI
Immune Correlates of Protection from TB$828,491
R01 · FY2017 · AI · contact PI
COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANS$734,575
R01 · FY2017 · AI
ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSIS$895,155
R01 · FY2016 · AI
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection$850,330
R01 · FY2016 · AI · contact PI
COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANS$746,671
R01 · FY2016 · AI
Development of Gleevec for TB and TB/HIV$599,999
UH2 · FY2016 · AI
ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSIS$15,462
R01 · FY2016 · AI
ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSIS$826,347
R01 · FY2015 · AI
Development of Gleevec for TB and TB/HIV$600,000
UH2 · FY2015 · AI
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection$467,190
R01 · FY2015 · AI · contact PI
Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates$503,945
R01 · FY2014 · AI · contact PI
Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates$730,427
R01 · FY2013 · AI · contact PI
Transcriptomics of Tuberculosis Latency and Reactivation in Primates$696,467
R01 · FY2013 · HL · contact PI
Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates$782,989
R01 · FY2012 · AI · contact PI
Transcriptomics of Tuberculosis Latency and Reactivation in Primates$751,864
R01 · FY2012 · HL · contact PI
Transcriptomics of Tuberculosis Latency and Reactivation in Primates$83,778
R01 · FY2012 · HL · contact PI
Transcriptomics of Tuberculosis Latency and Reactivation in Primates$756,737
R01 · FY2011 · HL · contact PI
Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates$567,851
R01 · FY2011 · AI · contact PI
M TUBERCULOSIS SIGH AND ITS REGULON IN THE IMMUNOPATHOLOGY OF TUBERCULOSIS$381,565
P20 · FY2011 · RR · contact PI
Role of miRNA in lung damage during TB and TB/AIDS Co-infection$204,188
R21 · FY2011 · AI · contact PI
TRANSCRIPTOMICS OF TUBERCULOSIS LATENCY AND REACTIVATION$57,750
P51 · FY2011 · RR · contact PI
ROLE OF MIRNA IN LUNG DAMAGE DURING TB AND TB/AIDS CO-INFECTION$57,750
P51 · FY2011 · RR · contact PI
MACAQUE MODEL OF TB/AIDS CO-INFECTION VIA NATURAL ROUTES OF EXPOSURE$57,750
P51 · FY2011 · RR · contact PI
CORRELATES OF IMMUNE PROTECTION AGAINST TB IN BCG VACCINATED NONHUMAN PRIMATES$37,186
P51 · FY2011 · RR · contact PI
GENETIC REQUIREMENTS FOR THE SURVIVAL OF TUBERCLE BACILLI IN NONHUMAN PRIMATES$37,186
P51 · FY2011 · RR · contact PI
A MULTI-DIMENSIONAL APPROACH TO UNDERSTANDING TB LATENCY AND REACTIVATION$37,186
P51 · FY2011 · RR · contact PI
DESIGNER ARRAYS FOR DEFINED MUTANT ANALYSIS IN A MACAQUE MODEL OF TUBERCULOSIS$37,186
P51 · FY2011 · RR · contact PI
THE CRUCIAL ROLE OF M TUBERCULOSIS SIGMA-H IN IMMUNOPATHOLOGY$37,186
P51 · FY2011 · RR · contact PI
DNA MICROARRAY AND EXPRESSION CORE$37,186
P51 · FY2011 · RR · contact PI
IN-VIVO GENE SILENCING IN MACAQUES$29,044
P51 · FY2011 · RR · contact PI
Transcriptomics of Tuberculosis Latency and Reactivation in Primates$790,087
R01 · FY2010 · HL · contact PI
Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates$571,220
R01 · FY2010 · AI · contact PI
M TUBERCULOSIS SIGH AND ITS REGULON IN THE IMMUNOPATHOLOGY OF TUBERCULOSIS$385,673
P20 · FY2010 · RR · contact PI
Role of miRNA in lung damage during TB and TB/AIDS Co-infection$247,500
R21 · FY2010 · AI · contact PI
Macaque model of TB/AIDS co-infection via natural routes of exposure$204,188
R21 · FY2010 · RR · contact PI
DNA MICROARRAY AND EXPRESSION CORE$61,801
P51 · FY2010 · RR · contact PI
DESIGNER ARRAYS FOR DEFINED MUTANT ANALYSIS IN A MACAQUE MODEL OF TUBERCULOSIS$61,801
P51 · FY2010 · RR · contact PI
THE CRUCIAL ROLE OF M TUBERCULOSIS SIGMA-H IN IMMUNOPATHOLOGY$61,801
P51 · FY2010 · RR · contact PI
MACAQUE MODEL OF TB/AIDS CO-INFECTION VIA NATURAL ROUTES OF EXPOSURE$61,801
P51 · FY2010 · RR · contact PI
DETERMINANTS OF PROTECTIVE IMMUNITY TO TUBERCULOSIS$39,400
P51 · FY2010 · RR · contact PI
CORRELATES OF IMMUNE PROTECTION AGAINST TB IN BCG VACCINATED NONHUMAN PRIMATES$39,400
P51 · FY2010 · RR · contact PI
Macaque model of TB/AIDS co-infection via natural routes of exposure$247,500
R21 · FY2009 · RR · contact PI
M TUBERCULOSIS SIGH AND ITS REGULON IN THE IMMUNOPATHOLOGY OF TUBERCULOSIS$213,617
P20 · FY2009 · RR · contact PI
DESIGNER ARRAYS FOR DEFINED MUTANT ANALYSIS IN A MACAQUE MODEL OF TUBERCULOSIS$57,967
P51 · FY2009 · RR · contact PI
THE CRUCIAL ROLE OF M TUBERCULOSIS SIGMA-H IN IMMUNOPATHOLOGY$57,967
P51 · FY2009 · RR · contact PI
DNA MICROARRAY AND EXPRESSION CORE$57,967
P51 · FY2009 · RR · contact PI
CORRELATES OF IMMUNE PROTECTION AGAINST TB IN BCG VACCINATED NONHUMAN PRIMATES$34,816
P51 · FY2009 · RR · contact PI
DETERMINANTS OF PROTECTIVE IMMUNITY TO TUBERCULOSIS$34,816
P51 · FY2009 · RR · contact PI
M TUBERCULOSIS SIGH AND ITS REGULON IN THE IMMUNOPATHOLOGY OF TUBERCULOSIS$200,376
P20 · FY2008 · RR · contact PI
DNA MICROARRAY AND EXPRESSION CORE$24,103
P51 · FY2008 · RR · contact PI
DESIGNER ARRAYS FOR DEFINED MUTANT ANALYSIS IN A MACAQUE MODEL OF TUBERCULOSIS$24,103
P51 · FY2008 · RR · contact PI
THE CRUCIAL ROLE OF M TUBERCULOSIS SIGMA-H IN IMMUNOPATHOLOGY$24,103
P51 · FY2008 · RR · contact PI
DETERMINANTS OF PROTECTIVE IMMUNITY TO TUBERCULOSIS$13,897
P51 · FY2008 · RR · contact PI
THE CRUCIAL ROLE OF M TUBERCULOSIS SIGH IN PATHOGENESIS$96,847
P20 · FY2007 · RR · contact PI
THE CRUCIAL ROLE OF M TUBERCULOSIS IN IMMUNOPATHOLOGY$30,392
P51 · FY2007 · RR · contact PI
DNA MICROARRAY AND EXPRESSION CORE$30,391
P51 · FY2007 · RR · contact PI
DNA MICROARRAY AND EXPRESSION CORE$30,971
P51 · FY2006 · RR · contact PI